LRRK2 and Parkinson disease: In agreement with our results, leukocytes and PMBCs isolated from PD patients carrying the LRRK2-G2019S mutant exhibited differential expression and activation of p38 and JNK, but not ERK, compared to healthy controls [19], [48].